STOCKS TELEGRAPH

Tag: SRNE

  • 30+ Best Penny Stocks Under $5 To Buy for Long-Term

    30+ Best Penny Stocks Under $5 To Buy for Long-Term

    Stocks trading under the $5 mark, which are known as penny stocks, are usually favored by retail investors. Since penny stocks are highly volatile, they provide good opportunities for making short-term gains.

    However, upon closer inspection of penny stocks, one might be able to find cheap stocks with a strong profile and great market opportunity. Such stocks can prove to be very fruitful in the long term.

    Given that these stocks are near the lower end of their trajectory, they come with huge upside potential. There is a real possibility that they would blow up in the coming years and bag huge profits for their holders.

    Advantages and Disadvantages of Penny Stocks

    Advantages

    • High Potential Returns

      Penny stocks can provide substantial returns if invested wisely, as their low prices allow for significant price appreciation.

    • Accessible Entry Point

      Individuals with limited capital can enter the stock market with penny stocks, as they are more affordable than higher-priced stocks.

    • Market Volatility Opportunities

      The inherent volatility of penny stocks can present opportunities for short-term traders looking to profit from rapid price movements.

    Disadvantages

    • Lack of Liquidity

      Penny stocks often lack liquidity, making it challenging to buy or sell large quantities without affecting the stock price.

    • Higher Risk

      Penny stocks are associated with higher risk due to their susceptibility to market manipulation, lack of regulatory oversight, and potential for sudden price declines.

    • Limited Information Availability

      Compared to larger stocks, penny stocks may have limited financial information and analyst coverage, making it harder to assess their true value.

    Best Stocks Under $5 To Buy for Long-Term

    We have compiled a list of the 30+ best penny stocks under $5 with promising profiles and market opportunities. Investing in these stocks and holding them for the long term just might give your portfolio the boost it needs.

    Best Stocks Under 5 To Buy for Long-Term

    SNDL Inc. (SNDL)

    The first of the penny stocks under $5, which we present, is a diversified cannabis play, SNDL Inc. (SNDL).

    Formerly known as Sundial Growers Inc., SNDL is a Canada-based cannabis producer which has extended its reach into the alcohol industry.

    It now also operates retail pot shops across Canada after going through multiple acquisitions in the past year and a half.

    SNDL has been strategically diversifying its business beyond organic cannabis production to ensure its long-term success.

    In January 2023, it completed the acquisition of Valens, a move that transformed the company into a vertically integrated Canadian powerhouse.

    With a wide range of brands, a network of 197 cannabis retail stores, and cost-effective biomass sourcing, cultivation, and manufacturing facilities, SNDL has positioned itself as one of Canada’s largest manufacturers and retailers of adult-use cannabis.

    Since the Valens acquisition, SNDL has already achieved impressive cost savings, surpassing its original target of $10 million. Annual savings of over $13 million have been realized, with an additional $5 million expected in 2023.

    By 2024, synergies are projected to reach an annual run rate of over $30 million, complemented by $9 million in proceeds from asset sales.

    Furthermore, SNDL’s proposed strategic partnership with Nova Cannabis Inc., in which SNDL holds a 63% ownership stake, has been approved by Nova’s shareholders.

    This partnership aims to establish a well-capitalized cannabis retail platform, leveraging SNDL’s expertise and resources. The Nova Restructuring is set to conclude by the end of June 2023.

    With a solid financial position and long-term investments totaling CAD 900 million, SNDL appears to be on a promising trajectory.

    The company has the potential to become a leading cannabis provider in Canada over the next decade. Patient investors may find substantial returns in SNDL, especially considering its current stock price below $5.

    Additionally, Wall Street analysts suggest a near-term price target that implies an attractive 172.8% upside potential.

    Terran Orbital Corporation (LLAP)

    Terran Orbital Corporation (LLAP) is a technology company in the space industry that’s known for producing satellites. This has become an increasingly attractive field thanks to a recent wave of merger and acquisition activity in the industry.

    Terran Orbital has recently announced the successful completion of CAPSTONE’s primary mission, marking a significant milestone in space exploration.

    CAPSTONE effectively navigated to and within the Near Rectilinear Halo Orbit (NRHO), showcasing its advanced capabilities.

    It also conducted a groundbreaking test of the Cislunar Autonomous Positioning System (CAPS) in collaboration with NASA’s Lunar Reconnaissance Orbiter (LRO).

    Moreover, CAPSTONE captured remarkable images of the Moon, adding to its list of achievements.

    Since entering NRHO, the CAPSTONE mission has accomplished several noteworthy milestones, including 28 successful orbits and seven on-orbit maneuvers.

    Additionally, it published 89 precise orbit-determination navigation solutions, further enhancing the understanding of celestial bodies.

    The mission collected over 315,000 measurements through the Deep Space Network, utilizing the facilities at Morehead State University, which played a crucial role in supporting the mission.

    Another remarkable aspect of the CAPSTONE mission was its observation of six lunar eclipses, with the longest lasting an impressive 74.32 minutes.

    These achievements reflect Terran’s dedication to pushing the boundaries of space exploration and its commitment to collaboration with industry partners like Lockheed Martin.

    penny stocks under $5: Terran Orbital Corporation (LLAP)

    While Terran’s market capitalization stands at approximately $180 million, profitability remains a challenge.

    However, with the potential for increased revenue generation and ongoing partnerships, such as the one with Lockheed Martin, Terran may soon experience positive earnings per share.

    This represents a significant step forward for the company and underscores its potential for future success.

    In fact, Wall Street anticipates the stock to surge by a mammoth 415% over the next 12 months. With such huge upside potential and a promising pipeline, it stands firm among our pick of penny stocks under $5 for long-term investment.

    Vivakor Inc. (VIVK)

    Up next on our list of penny stocks under $5 is an American company, Vivakor Inc. (VIVK). Vivakor specializes in clean energy technologies and environmental solutions including soil remediation.

    With the increasing awareness of the need for clean energy solutions, investments are rising in the sector. Thus, the clean energy technology market is growing at a rapid pace and the market opportunity is huge.

    Overall, the energy industry is seeing some strong tailwinds which are contributing to a huge rise in the energy stock trend.

    In just one year at close of the fiscal 2022 in December, its revenue skyrocketed to $28.1 million, a remarkable leap from $1.1 million the previous year.

    This extraordinary growth was primarily driven by the significant increase in sales of oil and natural gas liquids, thanks to its recent acquisitions of Silver Fuels Delhi, LLC.

    Furthermore, its gross profit for the same period rose to $2.9 million, compared to a stagnant $0.0 million in the previous year.

    As a result, its gross margin for the twelve months ended December 31, 2022, stood at an impressive 10.2%, significantly higher than the 3.5% recorded for the twelve months ended December 31, 2021.

    Currently, at a distance of just -2.32%, the stock has yet to break and hold above its 50-day moving average, it has been gaining traction year to date at 9.02%. The energy industry is gaining huge popularity and clean energy even more so.

    And Vivakor is capitalizing well on this market opportunity. All in all, Vivakor presents a great buy right now with the potential to bag huge amounts of profits in the future.

    Ambev SA (ABEV)

    Next in the line of penny stocks under $5 is a Brazil-based brewing company, Ambev SA (ABEV). Ambev has operations in 18 countries in South America and the Caribbean.

    It produces and distributes beer, soft drinks, and other non-alcoholic beverages. Given that 62% of the company is owned by Anheuser-Bush InBev, Ambev is essentially a business unit of the world’s largest brewing company.

    Both companies have been struggling due to the pandemic, but the reopening tailwinds have put Ambev back on track. However, the macroeconomic conditions have resulted in a considerable rise in commodity prices.

    But despite this, the brewer has been able to improve margins due to its strong pricing power. On the financial front, the company is doing pretty well.

    In the first quarter of 2023, Ambev delivered a 15.24% year-over-year improvement in profits on solid net revenue growth. During the quarter net income was BRL 3.70 billion, while the net revenue grew by nearly 11.35%.

    The organic EBITDA also marked a nice improvement of 8.5% year-over-year. Meanwhile, Ambev’s stock trades at a nice forward price-to-earnings ratio of 16.02.

    Add to this a dividend yield of 4.83% and you have got a penny stock worth buying for the long term. At a price of just under $3, ABEV is worth investing in.

    Broadwind (BWEN)

    The last of the penny stocks under $5 on our list is Broadwind (BWEN). Broadwind is one of the leading fabricators of equipment and components across different energy sectors.

    It covers both renewables and non-renewable, thus, diversifying its offerings in the broader energy industry.

    In the renewables sector, Broadwind focuses on wind power. It claims to be one of the first producers of 100-meter wind turbine towers in the U.S.

    Broadwind has excelled operationally and commercially, building a leading precision manufacturing platform.

    The company aims for organic growth in existing and adjacent markets, diversifying its revenue mix beyond wind, optimizing assets, and managing capital wisely.

    Over the past three years, Broadwind pursued an aggressive strategy, securing an $8 million order for its Mobile Pressure Reducing Systems (PRS) and expanding into new customer relationships.

    The company expects its clean fuels product offering to contribute 10% of total revenue by 2025. Non-wind revenue has grown by 45% since 2018, reaching a record $91.6 million in 2022, with continued growth in 2023.

    Broadwind aims to optimize its assets for better economies of scale by leveraging lean operating practices and focusing on high-return manufacturing processes.

    Furthermore, Broadwind came out with total revenue of $48.9 million in the first quarter of 2023. This marked a double-digit increase of 17% year-over-year due to the fast pace of the wind market as the wind market started recovering this year.

    penny stocks under $5: Broadwind (BWEN)

    The company’s backlog also showed a nice improvement of over $170 million. All in all, with the renewable market regaining traction and making a recovery, Broadwind is well-placed to capitalize on the opportunity.

    Therefore, to buy stocks under $5, this energy industry penny stock has great potential to bag some nice gains over the long run.

    In addition, we have compiled a list of 35 of the best stocks to buy under $5 you can consider in 2023.

    No. Ticker Company Performance (YTD) 50-Day Simple Moving Average Price
    1 QBTS D-Wave Quantum Inc. 79.06% 244.73% 2.58
    2 WLDS Wearable Devices Ltd. 339.95% 167.78% 1.92
    3 EFTR eFFECTOR Therapeutics, Inc. 229.75% 157.73% 1.41
    4 FRZA Forza X1, Inc. 119.53% 118.95% 2.81
    5 UTME UTime Limited 152.10% 109.25% 2.25
    6 DHC Diversified Healthcare Trust 250.19% 103.96% 2.27
    7 BVS Bioventus Inc. 13.99% 101.44% 2.98
    8 CNTX Context Therapeutics Inc. 97.94% 93.49% 1.29
    9 CRVS Corvus Pharmaceuticals, Inc. 291.76% 91.50% 3.33
    10 RGTI Rigetti Computing, Inc. 54.28% 87.54% 1.12
    11 RMTI Rockwell Medical, Inc. 323.15% 74.47% 4.3
    12 CNSP CNS Pharmaceuticals, Inc. 12.50% 72.20% 2.7
    13 CGEN Compugen Ltd. 77.43% 71.33% 1.27
    14 GRCL Gracell Biotechnologies Inc. 59.13% 70.76% 3.66
    15 LTCH Latch, Inc. 93.20% 67.90% 1.37
    16 MPLN MultiPlan Corporation 61.30% 66.99% 1.86
    17 KOPN Kopin Corporation 66.94% 66.49% 2.07
    18 TSP TuSimple Holdings Inc. 41.98% 64.67% 2.33
    19 ORGO Organogenesis Holdings Inc. 56.88% 63.34% 4.22
    20 INTR Inter & Co, Inc. 38.82% 61.72% 3.29
    21 BIOR Biora Therapeutics, Inc. 50.95% 58.50% 4.97
    22 OTLK Outlook Therapeutics, Inc. 74.07% 55.24% 1.88
    23 UBX Unity Biotechnology, Inc. 28.83% 48.44% 3.53
    24 GMDA Gamida Cell Ltd. 76.36% 47.45% 2.28
    25 FFIE Faraday Future Intelligent Electric Inc. 25.73% 46.09% 0.37
    26 REKR Rekor Systems, Inc. 54.17% 44.65% 1.85
    27 REAL The RealReal, Inc. 43.32% 43.93% 1.79
    28 MDVL MedAvail Holdings, Inc. 18.41% 43.77% 0.35
    29 GOL Gol Linhas Aereas Inteligentes S.A. 52.06% 42.71% 4.06
    30 AKBA Akebia Therapeutics, Inc. 116.64% 41.37% 1.25
    31 CBAT CBAK Energy Technology, Inc. 22.22% 40.32% 1.21
    32 XFOR X4 Pharmaceuticals, Inc. 110.05% 39.09% 2.09
    33 BTBT Bit Digital, Inc. 387.50% 38.84% 2.92
    34 AMRX Amneal Pharmaceuticals, Inc. 28.39% 38.74% 2.56
    35 AAOI Applied Optoelectronics, Inc. 44.44% 36.93% 2.73

    Best Online Brokers for Stocks Under $5

    When investing in penny stocks, it is crucial to choose a reliable online broker that offers the necessary tools and services for trading such securities. Some of the best online brokers for the best stocks to buy under $5 include:

    TD Ameritrade: Empowering Novices with Unparalleled Investment Resources

    TD Ameritrade comes highly recommended for newcomers, thanks to its vast wealth of knowledge, empowering investors as they venture into the realm of financial opportunities.

    The platform boasts a diverse range of educational resources, encompassing an extensive collection of 200+ instructional videos and tutorials.

    Ensuring a judgment-free environment, TD Ameritrade welcomes and encourages investment-related inquiries from beginners.

    They extend their support across multiple platforms, such as Facebook Messenger and Amazon Alexa devices, enabling convenient interactions with the brand.

    Moreover, TD Ameritrade presents two mobile trading applications, namely TD Ameritrade Mobile and thinkorswim Mobile. These apps offer trading accessibility and a plethora of features, unrestricted by geographical constraints.

    Fidelity Investments: A Beginner-Friendly Broker with Unmatched Services

    Fidelity Investments stands out as an immensely investor-friendly brokerage, making it an exceptional option for novices to buy stocks under $5.

    The company offers an extensive array of services and excels in delivering exceptional client support, particularly through telephonic assistance, where elaborate inquiries can be addressed in mere moments.

    The research reservoirs accessible at Fidelity are vast, encompassing a diverse selection of reports to aid investors. Whether you’re seeking the fundamentals of intelligent investing or profound expertise in specific domains, Fidelity has you covered.

    They offer webinars and recorded sessions that encompass nearly every facet of investment, ensuring the swift acquisition of the requisite wisdom.

    Navigating Fidelity’s website is an effortless task, as it is meticulously designed to be user-friendly, enabling you to effortlessly discover sought-after information without any inconvenience.

    Interactive Brokers: Low Costs and Extensive Resources For Investors

    Interactive Brokers comprehends the significance of maintaining economical expenses for both novices and proficient investors.

    The organization excels in this domain, commencing commissions at $0 via its Lite pricing strategy and offering more than 19,000 mutual funds devoid of transaction fees.

    Moreover, Interactive Brokers refrains from imposing any transfer-out fees, a common practice observed among other brokerage firms.

    Alongside their cost-effective approach, Interactive Brokers delivers robust research options and educational materials.

    These resources encompass instructional articles, webinars, and a comprehensive training program designed to enhance investors’ understanding.

    They provide round-the-clock assistance through telephone and chat systems, ensuring the timely resolution of queries.

    Ally Invest: A Fresh Approach to Brokerage With Unique Features

    Ally Invest emerges as a fresh contender within the brokerage domain, presenting a robust choice for individuals already engaged with Ally Bank and in pursuit of a convenient avenue for venturing into the realm of investments.

    Ally Invest furnishes a mobile application that grants users access to their accounts, facilitates quotation retrieval, and enables trade execution.

    The organization is widely acclaimed for its exceptional customer support and forward-thinking digital banking functionalities.

    The process of swiftly and seamlessly transferring funds from one’s bank account to the investment account is a notable convenience.

    Furthermore, Ally Invest delivers an information hub housing captivating content, distinguished by its enjoyable prose, in stark contrast to conventional financial resources.

    Robinhood: Empowering Novice Investors with Cost-Effective Options

    Robinhood appeals to newcomers who prioritize affordability, making it one of the best options to buy stocks under $5. The platform facilitates trading without charging commissions for stocks, ETFs, options, and cryptocurrencies.

    Moreover, Robinhood permits users to buy fractional shares, eliminating the necessity for substantial capital to initiate investments.

    Robinhood

    With its intuitive mobile application, Robinhood streamlines trading while enabling convenient monitoring of portfolios.

    Furthermore, the company has enhanced its customer support services, providing round-the-clock assistance via chat and phone to ensure the timely resolution of queries, irrespective of the hour.

    Where To Buy Penny Stocks Under $5

    Penny stocks under $5 present an enticing opportunity to enter the stock market and potentially reap substantial returns. While penny stocks can be volatile and risky, they can also be rewarding if approached wisely.

    Finding the right marketplace to purchase penny stocks is essential. Here are a few popular options:

    • Major Stock Exchanges

      Some penny stocks are listed on established exchanges like the New York Stock Exchange (NYSE) and NASDAQ, providing increased transparency and credibility.

    • Over-the-Counter (OTC) Markets

      OTC markets, such as OTCQB and Pink Sheets, facilitate the trading of penny stocks not listed on major exchanges. However, caution is necessary due to lower regulatory standards.

      This opens up a realm of possibilities, with numerous penny stocks available at low prices.

    • Direct Stock Purchase Plans (DSPPs)

      Direct Stock Purchase Plans (DSPPs) is an excellent option for investors who prefer a hands-on approach and direct ownership of penny stocks.

      DSPPs enable investors to purchase stocks directly from the issuing company, bypassing the need for a broker. Many companies offer these plans, allowing individuals to invest small amounts of money and accumulate shares over time.

      While DSPPs may have specific restrictions, they provide a unique opportunity to invest directly in promising penny stocks without the need for an intermediary.

    Features To Look For In Stocks Under $5

    When evaluating the best stocks to buy under $5, consider the following features to make informed investment decisions:

    • Strong Fundamentals

      Look for companies with solid financials, including healthy revenue growth, strong balance sheets, and positive cash flow. Assess factors like earnings per share (EPS), profit margins, and debt levels to determine financial stability.

    • Growth Potential

      Identify stocks with promising growth prospects. Analyze industry trends, market demand, and the company’s competitive advantage. Look for companies positioned to capitalize on emerging technologies or expanding markets.

    • Positive Catalysts

      Consider stocks with upcoming positive catalysts such as new product launches, strategic partnerships, or regulatory approvals. These events can potentially drive stock prices upward.

    • Management Competence

      Evaluate the company’s management team and its track record. Look for experienced leaders who have successfully navigated challenges and delivered on their promises.

    • Liquidity And Volume

      Ensure that the stock has sufficient trading volume to facilitate buying and selling without significant price impact. Adequate liquidity is crucial, as it allows investors to enter and exit positions efficiently.

    • Risk Assessment

      Understand the risks associated with the company and its industry. Assess factors like competition, regulatory hurdles, market volatility, and potentially disruptive technologies that could impact the stock’s performance.

    Tips For Investing In Penny Stocks Under $5

    To maximize the potential of investing in penny stocks, consider the following tips:

    • Conduct Thorough Research: Diligently research companies, their financial statements, news releases, and any potential risks before investing.
    • Diversify Your Portfolio: Spread your investments across multiple penny stocks to mitigate the risks associated with individual companies.
    • Set Realistic Expectations: Understand the inherent volatility of penny stocks and set realistic goals based on careful analysis rather than speculation.

    Risks and Considerations in Investing in Penny Stocks

    Investing in penny stocks involves certain risks and considerations that should not be overlooked:

    • Volatility And Price Manipulation: Penny stocks are highly volatile and can be susceptible to price manipulation schemes.
    • Lack Of Transparency: Due to limited regulatory requirements, penny stocks may have less available information, making it harder to make informed decisions.
    • Capital Loss: Investments in penny stocks carry the risk of losing the entire investment if the company fails or the stock’s value plummets.

    Importance of Diligence and Monitoring

    To succeed in penny stock investing, diligence, and monitoring are of utmost importance:

    • Continuous Due Diligence

      Regularly assess the performance of your penny stocks, monitor news and company updates, and adapt your investment strategy accordingly.

    • Risk Management

      Implement risk management techniques, such as setting stop-loss orders, to protect your investments from significant losses.

    • Stay Informed

      Stay updated on market trends, economic indicators, and regulatory changes that can impact the performance of penny stocks.

    Conclusion

    Investing in penny stocks under $5 can be an attractive opportunity for investors seeking potentially high returns.

    However, it is vital to approach these investments with caution, understanding both the advantages and disadvantages they present.

    By choosing reliable online brokers, conducting thorough research, and practicing diligent monitoring, investors can navigate the risks associated with penny stocks and increase their chances of making informed investment decisions.

    Frequently Asked Questions

    What To Avoid When Shorting Stocks Under $5?

    When shorting stocks under $5, it’s crucial to avoid certain pitfalls. Firstly, avoid illiquid stocks with low trading volume, as exiting positions may prove difficult.

    Secondly, be cautious of stocks with high short interest, as sudden squeezes can cause substantial losses.

    Lastly, steer clear of companies with solid potential for a turnaround, as they may defy expectations. Prudent research is key.

  • Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    The American stock market finished trading with a slight loss on January 26. By the end of the session, the S & P 500 index dropped by 0.15% to 3850 points. NASDAQ and Dow Jones were down 0.07%. The news background stayed mostly calm, so the market showed weak dynamics. The energy sector fell 2.12% despite stable oil prices. The real estate sector became the leader in growth with a result of + 1.14% thanks to the continued favorable macroeconomic conditions in the housing market.

    Company news

    President Biden plans to transfer American officials to American-made electric cars. Against this background, shares of Workhorse (WKHS: + 30.2%), Lordstown (RIDE: + 14%), Nikola (NKLA: + 23.6%) and others rose.

    Beyond Meat (BYND: + 17.7%) has partnered with PepsiCo (PEP: + 1.2%) to co-manufacture and market plant-based meat substitute products.

    Johnson & Johnson (JNJ: + 2.7%) quarterly report better than expected. The company also announced that the test results for its vaccine will be released in early February.

    There are various dynamics in the global stock markets today. Pfizer and Moderna have both agreed to sell the US government 100 million additional doses of vaccine. Considering this order, the total volume of purchases will amount to 600 million. Over 300 million people can be vaccinated against coronavirus with just that amount. The number of hospitalized with COVID-19 in the United States fell to 108 thousand, which is in line with mid-December levels. The morbidity trend on a daily basis is on the decline. This allows the states to slowly remove barriers, which support investor confidence.

    The companies’ quarterly results and market reactions to them are still mixed. However, Microsoft’s report was strong, so the tech sector has the potential to become a growth engine for the broader market today.

    Economic news

    December durable goods base order data will be released this Wednesday. After increasing by 0.4% a month earlier, the indicator is expected to grow by 0.5% against the value in November. Note that basic orders do not include vehicles (cars, airplanes, etc.), and it is this group of products that may show the weakest dynamics against the background of continuing problems with orders from Boeing.

    Technical picture

    Technical analysis suggests that there is an upward tendency in the medium term for the S&P 500. The broad market index reached a new all-time high yesterday, but met selling pressure and failed to gain a foothold above 3860 points. The upper border of the equidistant channel in the area of ​​3865-3870 points is still a serious resistance. After a short-term consolidation, the upward movement is likely to continue.

    Today Top Movers‎

    ‎Virgin Galactic Holdings Inc (SPCE) share price jumped 11.65% to $46.95 during the early morning ‎trading session on ‎Wednesday.‎‎ SPCE has found itself making more headlines recently as billionaire rocketman, Richard Branson, gets closer to achieving his dream of taking tourists to the stars.‎ ‎‎

    ‎Digital Ally Inc (DGLY) grew over 14.18% at $3.14 in pre-market trading ‎today.‎‎‎ ‎‎

    ‎Moderna Inc (MRNA) stock moved up 1.49 percent to $154.19 in the pre-market ‎trading after the firm provided a supply update for the Moderna COVID-19 Vaccine.‎‎ ‎‎

    ‎Romeo Power Inc (RMO) gained 9.52% and closed at $20.25 on ‎Tuesday ‎January 26, 2021.‎‎

    Top Upgrades & Downgrades

    KeyBanc turned bullish on Dycom Industries Inc. (DY), upgrading the stock to “Overweight” and assigning a $104.0 price target, representing a potential downside of 18.3% from Tuesday’s close. 

    3M Company (MMM) has won the favor of JPMorgan’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $205, suggesting 16.51% additional upside for the stock. 

    The Wendy’s Company (WEN) received an upgrade from analysts at Deutsche Bank, who also set their one-year price target on the stock to $25. They changed their rating on WEN to Buy from Hold in a recently issued research note. 

    Earlier Wednesday KeyBanc reduced its rating on Visa Inc. (V) stock to Sector Weight from Overweight.

    KeyBanc analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for MasTec Inc. (MTZ) has been changed to Sector Weight from Overweight.

    Analysts at KeyBanc downgraded Mastercard Incorporated (MA)’s stock to Sector Weight from Overweight Wednesday.

    Latest Insider Activity

    United States Antimony Corporation (UAMY) 10% Owner Reed Kenneth M announced the sale of shares taking place on Jan 26 at $0.98 for some 540,275 shares. The total came to more than $0.53 million. 

    Sorrento Therapeutics Inc. (SRNE) Director Followwill Dorman sold on Dec 16 a total of 2,130 shares at $7.14 on average. The insider’s sale generated proceeds of almost $7135.0. 

    Harbor Custom Development Inc. (HCDI) Director SWETS LARRY G JR declared the purchase of shares taking place on Jan 15 at $3.00 for some 35,000 shares. The transaction amount was around $0.1 million. 

    Urban One Inc. (UONE) 10% Owner SEMLER ERIC bought on Jan 19 a total 2,221,197 shares at $4.15 on average. The purchase cost the insider an estimated $829,170.

    Important Earnings

    Top US earnings releases scheduled for today include Tesla Inc. (NASDAQ: TSLA). It will announce its Dec 2020 financial results. The company is expected to report earnings of $1.01 per share from revenues of $10.32B in the three-month period. 

    Analysts expect Facebook Inc. (NASDAQ: FB) to report a net income (adjusted) of $3.22 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $26.43B. 

    Apple Inc. (AAPL), due to announce earnings after the market closes today, is expected to report earnings of $1.41 per share from revenues of $103.28B recently concluded three-month period.

  • Market Movers: What changed for these 21 stocks while you were sleeping

    Market Movers: What changed for these 21 stocks while you were sleeping

    ‎Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -‎‎5.88% ‎at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund.‎

    ‎ATIF Holdings Limited (ATIF) stock plunged -8.51% to $0.9698 in the pre-‎market ‎trading.‎

    ‎Bionano Genomics Inc. (BNGO) stock soared 8.57% to $0.96 in the pre-‎market ‎trading after declaring that Praxis Genomics, LLC received accreditation from the College of ‎American ‎Pathologists (CAP). The most recent rating by Ladenburg Thalmann, on September 24, 2020, ‎is a Buy. ‎

    ‎Zomedica Corp. (AMEX: ZOM) shares are trading up 4.5% at $0.2625 at the ‎time ‎of ‎writing. Company’s 52-week ranged between $0.06 to $0.50.‎

    ‎Nano Dimension Ltd. (NASDAQ: NNDM) shares are trading up 5.52% at $8.6 at ‎the ‎time of writing after pricing $250 million registered direct offering. ‎Company’s 52-week ‎ranged ‎between $0.51 to $10.49. Analysts have a consensus price target of $8. ‎

    ‎Jaguar Health Inc. (JAGX) stock moved down -2.88 percent to $0.7325 in the pre-‎‎market trading.‎

    ‎Ideanomics Inc. (IDEX), a Software – Application company, rose about 4.27% at ‎‎$2.44 ‎in pre-market trading Tuesday following the declaration the signing of an agreement of its ‎Mobile ‎Energy Global (“MEG”) and contracting entity Qingdao Chengyang Medici with Meihao ‎Chuxing, a joint ‎venture between BYD and Didi, to purchase an initial 2,000 units of model BYD D1. ‎

    ‎Alibaba Group Holding Limited (BABA) is up more than 3.64% at $230.45 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 0.16% to $222.36 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, FuelCell Energy Inc. (FCEL) is ‎up ‎‎2.3% to reach $11.81. It has been trading in a 52-week range of $0.84 to $13.91.‎

    ‎AeroCentury Corp. (ACY) lost over -25.7% at $10.29 in pre-market trading ‎Tuesday ‎December 29, 2020 following the update of listing standards compliance.‎

    ‎Color Star Technology Co. Ltd. (CSCW) is down more than -9.21% at $0.69 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 7.04% to $0.76 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, Guardion Health Sciences ‎Inc. ‎‎(GHSI) is up 14.83% to reach $0.36. The firm recently reported the appointment of ‎Bret ‎Scholtes, as its President and Chief Executive Officer, and as a member of the Board of Directors. ‎He is ‎a veteran of the nutritional products industry for nearly a decade. It has been trading in a 52-‎week ‎range of $0.17 to $0.74.‎

    ‎Nokia Corporation (NOK) stock soared 2.31% to $3.99 in the pre-market ‎trading ‎after reporting that it has been selected by Thailand’s dtac as its first 5G partner.‎ The most ‎recent ‎rating by Exane BNP Paribas, on October 30, 2020, is a Neutral. ‎

    Before the trading started on December 29, 2020, Acasti Pharma Inc. (ACST) is ‎up ‎‎7.32% to reach $0.3343. It has been trading in a 52-week range of $0.17 to $2.75.‎

    ‎RMG Acquisition Corp. (RMG) grew over 2.1% at $32.61 in pre-market trading ‎today ‎following the stockholder approval of business combination with Romeo Systems, Inc. with ‎no ‎redemptions.‎

    ‎Aprea Therapeutics Inc. (APRE), a Biotechnology company, rose about 4.73% ‎at ‎‎$5.76 in pre-market trading Tuesday after declaring results of primary endpoint from Phase 3 trial ‎of ‎Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS).‎

    ‎MicroVision Inc. (NASDAQ: MVIS) shares are trading up 6.41% at $7.14 at ‎the ‎time ‎of writing. Company’s 52-week ranged between $0.15 to $9.74. Analysts have a consensus ‎price ‎target ‎of $4.50.‎

    ‎China Recycling Energy Corporation (CREG) is down more than -2.23% at $5.7 in pre-‎‎market hours Tuesday December 29, 2020 after revealing that it has entered into agreement to ‎acquire ‎Xi’an Taiying Energy Saving Technology ‎Co., Ltd..‎. The stock had jumped over 31.31% to $5.83 in ‎the last ‎trading session. ‎

    ‎BIOLASE Inc. (BIOL) stock moved up 25.44 percent to $0.6021 in the pre-‎market ‎trading.‎

    ‎Borr Drilling Limited (BORR), a Oil & Gas Drilling company, rose about 4.66% ‎at ‎‎$0.854 in pre-market trading Tuesday after reporting the appointment of Mr. Magnus Vaaler as its ‎new ‎Chief Financial Officer. He will replace Mr. Christoph Bausch.‎

    ‎Onconova Therapeutics Inc. (NASDAQ: ONTX) shares are trading up 3.68% ‎at ‎‎$0.465 ‎at the time of writing. Company’s 52-week ranged between $0.19 to $1.56. Analysts have ‎a ‎consensus ‎price target of $7.50.‎

  • 24 stocks trending in pre-market

    ‎Ocugen Inc. (OCGN) stock soared 77.6% to $1.43 in the pre-market trading after ‎signing a binding letter of intent (LOI) with Bharat Biotech to develop Bharat Biotech’s COVID-19 ‎vaccine candidate, COVAXIN, for the United States market.‎

    ‎Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 1.25% at $0.486 at the ‎time of writing after announcing completion of financial restructuring and debt-free status. Company’s ‎‎52-week ranged between $0.14 to $3.88. COVID-19 Pandemic – The government presents its daily ‎update.‎

    ‎Jaguar Health Inc. (JAGX), a Biotechnology company, rose about 55.89% at $0.617 in ‎pre-market trading Wednesday after releasing voting results from special meeting of stockholders & ‎December 23rd investor webinar.‎

    ‎FuelCell Energy Inc. (FCEL) stock moved up 8.42 percent to $11.65 in the pre-market ‎trading.‎

    ‎Onconova Therapeutics Inc. (ONTX) gained over 32.93% at $0.57 in pre-market ‎trading Wednesday December 23, 2020 following the announcement of FDA permission for study to ‎proceed under its investigational new drug application for multi-kinase CDK4/6 Inhibitor ON 123300.‎

    ‎Castor Maritime Inc. (CTRM) is up more than 2.39% at $0.1585 in pre-‎market ‎hours ‎Wednesday December 23, 2020. The stock had dropped over -2.33% to $0.15 in the ‎last ‎trading ‎session.‎

    ‎Riot Blockchain Inc. (RIOT) is down more than -4.4% at $14.0 in pre-market hours ‎Wednesday December 23, 2020 after reporting an expected 65% increase in bitcoin mining hash rate ‎capacity resulting from the purchase and future deployment of 15,000 S19 Pro and S19j Pro Antminers ‎from Bitmain Technologies Limited .The stock had jumped over 32.65% to $14.65 in the last trading ‎session.‎

    Before the trading started on December 23, 2020, Ideanomics Inc. (IDEX) is up ‎‎4.21% to reach $2.23. It has been trading in a 52-week range of $0.28 to $4.75.‎

    ‎Aurora Mobile Limited (JG) tumbled over -1.46% at $4.72 in pre-market trading ‎today after reporting that it has entered into a partnership agreement a global leading new energy ‎vehicle manufacturer to deliver an enhanced intelligent driving experience.‎

    ‎Velodyne Lidar Inc. (VLDR) is up more than 6.21% at $29.08 in pre-market hours ‎Wednesday December 23, 2020 after revealed the joining of the Qualcomm smart cities accelerator ‎program. The stock had jumped over 10.94% to $27.38 in the last trading session.‎

    ‎Magnite Inc. (NASDAQ: MGNI) shares are trading up 17.21% at $31.81 ‎at ‎the ‎time ‎of ‎writing. Company’s 52-week ranged between $4.09 to $26.63. Analysts have ‎a ‎consensus ‎price ‎target ‎of $30.‎

    ‎Sorrento Therapeutics Inc. (SRNE) grew over 10.66% at $7.99 in pre-market trading ‎today after declaring that it has submitted an emergency use authorization application to the FDA for ‎COVI-STIX™ rapid test for the detection of SARS-CoV-2 Viral Antigen.‎

    ‎UP Fintech Holding Limited (TIGR), a Capital Markets company, dropped about -‎‎2.79% at $7.66 in pre-market trading Wednesday.‎

    ‎Energous Corporation (WATT) stock moved up 13.98 percent to $2.12 in the pre-‎market trading following the declaration from the company that current board director Dan Fairfax has ‎been named chairman of the board as current Chairman Robert J.‎

    ‎Acasti Pharma Inc. (ACST) stock soared 25.92% to $0.3148 in the pre-‎‎‎‎market ‎trading. ‎The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) gained over 5.15% at $0.6008 in pre-‎market trading Wednesday December 23, 2020 after revealing an agreement whereby Tonix has ‎acquired the exclusive license to the University of Geneva’s technology for using oxytocin to treat ‎insulin resistance and related syndromes, including obesity, from privately held Katana ‎Pharmaceuticals, Inc.‎

    ‎BP p.l.c. (BP) is up more than 2.34% at $20.96 in pre-market hours Wednesday ‎December 23, 2020. The stock had dropped over -0.97% to $20.48 in the last trading session.‎

    Before the trading started on December 23, 2020, Evofem Biosciences Inc. (EVFM) ‎is up 6.61% to reach $2.58 after reporting that it will participate in Medicaid National Drug rebate ‎program for Phexxi® Effective January 1, 2021. It has been trading in a 52-week range of $1.91 to $7.21.‎

    ‎Cloudera Inc. (CLDR) is up more than 5.6% at $15.46 in pre-‎‎‎‎‎market ‎hours ‎Wednesday December 23, 2020. The stock had jumped over 13.31% ‎to ‎‎$14.64 ‎in ‎the ‎last ‎trading ‎session.‎

    ‎Advaxis Inc. (ADXS) stock soared 39.07% to $0.4357 in the pre-market trading ‎following the announcement of listing transfer to Nasdaq Capital Market and additional 180-day ‎eExtension by Nasdaq to regain compliance with minimum bid price rule.‎ The most recent rating by ‎Barclays, on August 03, 2016, is an Overweight. ‎

    ‎Nikola Corporation (NASDAQ: NKLA) shares are trading down -2.97% at $16.33 at ‎the time of writing after reporting that Nikola and Republic Services (NYSE: RSG) have discontinued ‎their collaboration on refuse truck development. Company’s 52-week ranged between $10.30 to ‎‎$93.99. Analysts have a consensus price target of $20.‎

    Before the trading started on December 23, ‎‎2020, ‎‎Oragenics ‎Inc. ‎‎(OGEN) ‎is ‎up ‎‎8.3% ‎to reach $0.4841. It has been trading in a 52-‎week ‎range of $0.36 to ‎‎$2.09.‎

    ‎Bionano Genomics Inc. (BNGO) grew over 1.45% at $0.56 in pre-market trading ‎today after reporting publication revealing in side-by-side comparison that method using PacBio ‎sequencing detects only 72% of the large structural variants detected by Optical Genome Mapping ‎with Saphyr.‎

    ‎Palatin Technologies Inc. (PTN) gained over 7.96% at $0.61 in pre-‎‎‎‎‎‎‎market ‎trading ‎Wednesday December 23, 2020.‎

  • What changed for these 31 stocks in Pre Market Session

    What changed for these 31 stocks in Pre Market Session

    Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market under Nasdaq Rules. The most recent rating by Maxim Group, on January 08, 2020, is a Buy.
    Curis Inc. (CRIS), a Biotechnology company, dropped about -5.72% at $7.25 in pre-market trading Thursday after declaring the pricing of an underwritten public offering of 25,652,174 shares of its common stock at a public offering price of $5.75 per share for total gross proceeds of approximately $147.5 million.
    ZW Data Action Technologies Inc. (CNET) lost over -11.33% at $1.8 in pre-market trading Thursday December 10, 2020 after reporting the official opening of its first live streaming platform in Guangzhou, China.
    Genius Brands International Inc. (GNUS) is up more than 9.74% at $1.69 in pre-market hours Thursday December 10, 2020. The firm recently revealed that it will be presenting at the 13th Annual LD Micro investor conference on Tuesday, December 15th at 10:00 a.m. PST / 1:00 p.m. EST. The stock had dropped over -4.35% to $1.54 in the last trading session.
    Rocket Companies Inc. (RKT), a Mortgage Finance company, rose about 3.09% at $21.71 in pre-market trading Thursday following the release of Clear HOI platform from its subsidiary to mortgage lenders nationwide.
    Intec Pharma Ltd (NTEC) stock moved down -7.76 percent to $4.28 in the pre-market trading. Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma.
    Atossa Therapeutics Inc. (ATOS) gained over 2.31% at $0.8919 in pre-market trading Thursday December 10, 2020 after revealing cannabinoid research collaboration with GW Pharma.
    Nano Dimension Ltd. (NNDM) is up more than 2.25% at $6.82 in pre-market hours Thursday December 10, 2020 following the declaration from the company that it has closed the registered direct offering of 30,000,000 of the Company’s American Depositary Shares at a price of $6.00 per ADS. The stock had dropped over -6.06% to $6.67 in the last trading session.
    Before the trading started on December 10, 2020, Sorrento Therapeutics Inc. (SRNE) is down -2.44% to reach $8.01 following the FDA acceptance of its Investigational New Drug (IND) application for its Phase 1 clinical trials for intravenous (IV) STI-2020 (COVI-AMG). It has been trading in a 52-week range of $1.55 to $19.39.
    Genetic Technologies Limited (GENE) stock plunged -9.17% to $4.06 in the pre-market trading.
    Greenwich LifeSciences Inc. (GLSI) grew over 46.76% at $83.8 in pre-market trading today after reporting the publication of a poster for the GP2 Phase IIb clinical trial final efficacy analysis at the San Antonio Breast Cancer Symposium in a virtual format.
    Lipocine Inc. (LPCN), a Biotechnology company, dropped about -5.3% at $1.25 in pre-market trading Thursday after announcing that the U.S. Food and Drug Administration has granted tentative approval to TLANDO.
    SELLAS Life Sciences Group Inc. (SLS) stock moved up 51.8 percent to $9.7 in the pre-market trading. The biotechnology firm recently revealed exclusive license agreement with 3D Medicines for development and commercialization of Galinpepimut-S (GPS) and GPS+ in Greater China.
    Francesca’s Holdings Corporation (NASDAQ: FRAN) shares are trading down -10.68% at $2.51 at the time of writing after receiving court approval of “First Day” motions to support ongoing operations. Company’s 52-week ranged between $1.70 to $19.91. Analysts have a consensus price target of $2.50.
    Oncternal Therapeutics Inc. (ONCT) tumbled over -27.78% at $4.55 in pre-market trading today after announcing that the firm increased its previously declared bought deal to $75.0 million.
    Gran Tierra Energy Inc. (GTE) is down more than -2.83% at $0.35 in pre-market hours Thursday December 10, 2020. The company recently declared a financial update and the Company’s 2021 capital budget and production guidance. The stock had dropped over -5.68% to $0.36 in the last trading session.
    Before the trading started on December 10, 2020, Fisker Inc. (FSR) is down -4.04% to reach $16.15. The firm recently confirmed that it has signed agreements with Cox Automotive U.K. (“Cox”) and Rivus Fleet Solutions for delivery, servicing, fleet management and reselling programs in the United Kingdom. It has been trading in a 52-week range of $8.70 to $23.63.
    Immutep Limited (IMMP) stock soared 89.35% to $4.09 in the pre-market trading after declaring that its Chinese partner, EOC Pharma will commence a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China. The most recent rating by B. Riley FBR, on September 28, 2018, is a Buy.
    Remark Holdings Inc. (MARK), a Internet Content & Information company, rose about 3.09% at $1.67 in pre-market trading Thursday after reporting that Remark’s KanKan AI business successfully released its edge computing systems, the S and T Series Smart Boxes.
    Baidu Inc. (BIDU) gained over 2.42% at $155.26 in pre-market trading Thursday December 10, 2020. The firm recently released new intelligent vehicle solutions for automakers and several high-end intelligent driving products during the second Apollo Ecosystem Conference.
    Before the trading started on December 10, 2020, Editas Medicine Inc. (EDIT) is up 9.13% to reach $55.2 after reporting submission of IND application for EDIT-301 with the FDA. It has been trading in a 52-week range of $14.01 to $43.65.
    Artelo Biosciences Inc. (ARTL) stock plunged -2.47% to $0.66 in the pre-market trading. The healthcare firm recently declared that it has filed a composition of matter patent application directed to a new solid dosage formulation, including its method of use, with the UK Patent Office.
    AquaBounty Technologies Inc. (NASDAQ: AQB) shares are trading down -17.07% at $7.19 at the time of writing following the selection of Innovasea as the Recirculating Aquaculture Systems (“RAS”) technology provider for its planned 10,000 metric ton farm. Company’s 52-week ranged between $1.52 to $11.40. Analysts have a consensus price target of $5.
    Pluristem Therapeutics Inc. (PSTI) lost over -5.57% at $6.61 in pre-market trading Thursday December 10, 2020 after declaring DMC recommendation following interim analysis of its phase III CLI study.
    Before the trading started on December 10, 2020, Veru Inc. (VERU) is up 25.96% to reach $4.9 after reporting that it has exclusively licensed worldwide rights to enobosarm, a late-stage oral novel androgen receptor (AR) targeting agent for the treatment of endocrine resistant ER+ HER2- metastatic breast cancer. It has been trading in a 52-week range of $2.10 to $4.74.
    Uranium Energy Corp. (AMEX: UEC) shares are trading down -4.32% at $1.33 at the time of writing. Company’s 52-week ranged between $0.35 to $1.59. Analysts have a consensus price target of $1.50.
    Boxlight Corporation (BOXL), a Communication Equipment company, rose about 7.23% at $1.78 in pre-market trading Thursday. The firm recently confirmed that they are the recipients of three THE Journal’s Best New EdTech Product Awards.
    Regulus Therapeutics Inc. (RGLS) stock moved up 19.34 percent to $1.07 in the pre-market trading. The company lately announced closing of $19.4 million private placement of equity.
    Before the trading started on December 10, 2020, Sea Limited (SE) is down -3.3% to reach $196.0 after reporting that it proposes to offer 11,000,000 American Depositary Shares, each representing one Class A ordinary share of the Company, in an underwritten public offering. It has been trading in a 52-week range of $35.61 to $207.51.
    Barclays PLC (NYSE: BCS) shares are trading down -3.85% at $7.5 at the time of writing. The firm recently revealed the launch of BARX Book for Equities, a new single-dealer platform developed in partnership with Nasdaq (Nasdaq: NDAQ). Company’s 52-week ranged between $3.41 to $10.22.
    Qualigen Therapeutics Inc. (QLGN) stock moved up 13.85 percent to $4.44 in the pre-market trading. The company recently announced board member Amy Broidrick as EVP, Chief Strategy Officer and named Sidney Emery, Jr. to its board.

  • Top key players of Biotech Industry

    Top key players of Biotech Industry

    It is evident with so many people focused on COVID-19 that biotech stocks with coronavirus vaccines and treatments have gained a lot of attention.

    The Pfizer and BioNTech vaccine is developed on mRNA science, more straightforward, quicker, and cheaper to produce than standard vaccines. Even so, amid the enormous capital and expertise of Pfizer, the large pharmaceutical firm has failed to reach the production goals it initially set for the vaccine, needing to cut the original 100 million doses in 2020 to 50 million last month.

    The development issues are not restricted to vaccines for Covid-19 either. The FDA authorized the use of antibody drugs to treat Covid-19 last month, for example, complicated to develop. Other indications include diagnostics and cell therapies are in development. Flowing are the key performers from the Biotech sectors in yesterday’s market session.

    Xenetic Biosciences Inc. (NASDAQ:XBIO) shares were trading up 193.52% at $3.17 at the time of writing on Wednesday following declaration that it saw positive data from its partner PJSC Pharmsynthez about its pivotal Phase 3 clinical study leveraging PolyXen to develop a treatment for anemia in patients with chronic kidney disease (CKD).

    Xenetic Biosciences Inc. (NASDAQ:XBIO) share price went from a low point around $0.44 to briefly over $1.85 in past 52 weeks, though shares have since pulled back to $3.17. XBIO market cap has remained high, hitting $20.45M at the time of writing, giving it price-to-sales ratio of more than 60.

    If we look at the recent analyst rating XBIO, Maxim Group initiated coverage on XBIO shares with a Buy rating.

    Moderna Inc. (MRNA) last closed at $156.59, in a 52-week range of $17.68 to $178.50. The healthcare firm recently declared that the Swiss Federal Government has increased its confirmed order commitment from 4.5 million to 7.5 million doses of Moderna’s vaccine candidate against COVID-19, mRNA-1273. Analysts have a consensus price target of $122.60.

    GeoVax Labs Inc. (GOVX) stock soar by 79.06% to $5.73. The company on November 30, 2020 reported license agreement with NIH to support continued advancements in vaccine development. The most recent rating by Maxim Group, on November 19, 2020, is at a Buy.

    Intec Pharma Ltd (NASDAQ:NTEC) Shares headed rising, higher as much as 34.10% after declaring that it has entered into a feasibility agreement with GW Research Limited, London, U.K. to explore using the Accordion Pill (AP) platform for an undisclosed research program.. The most recent rating by Ladenburg Thalmann, on December 09, 2020, is at a Buy.

    Atossa Therapeutics Inc. (NASDAQ:ATOS) fall -39.03% after losing more than -$0.56 on Wednesday after the company reported pricing of $20.0 million underwritten public offering.

    Sorrento Therapeutics Inc. (SRNE) last closed at $8.21, in a 52-week range of $1.55 to $19.39. The company reported that it received US FDA clearance to proceed with Phase 1 Clinical Trials for STI-2020 (COVI-AMG) in healthy volunteers and in newly diagnosed COVID-19 Patients.

    Greenwich LifeSciences Inc. (GLSI) stock soar by 998.35% to $57.10 after reporting the publication of a poster for the GP2 Phase IIb clinical trial final efficacy analysis at the San Antonio Breast Cancer Symposium in a virtual format.

    Jaguar Health Inc. (NASDAQ:JAGX) Shares headed falling, lower as much as -11.45%. The most recent rating by Rodman & Renshaw, on July 11, 2017, is at a Buy.

    Lipocine Inc. (NASDAQ:LPCN) fall -21.43% after losing more than -$0.36 on Wednesday following the announcement from the company that the U.S. Food and Drug Administration has granted tentative approval to TLANDO

    Tonix Pharmaceuticals Holding Corp. (TNXP) last closed at $0.64, in a 52-week range of $0.39 to $2.46. On December 3, 2020, the firm declared positive phase 3 RELIEF study results for TNX-102 SL 5.6 mg in Fibromyalgia.

    SELLAS Life Sciences Group Inc. (SLS) stock soar by 73.17% to $6.39. The company on December 7, 2020 revealed an exclusive license agreement with 3D Medicines for development and commercialization of Galinpepimut-S (GPS) and GPS+ in Greater China. The most recent rating by Oppenheimer, on November 01, 2018, is at an Outperform.

    AIkido Pharma Inc. (NASDAQ:AIKI) Shares headed rising, higher as much as 4.07% after declaring the publication of positive results from its Artificial Intelligence/Machine Learning Sponsored Research Program in the field of Pancreatic Cancer.

    Celsion Corporation (NASDAQ:CLSN) rose 12.90% after gaining more than $0.08 on Wednesday.

    ADMA Biologics Inc. (ADMA) last closed at $2.22, in a 52-week range of $1.45 to $4.65. The firm recently announced $100 million credit facility loan amendment with perceptive advisors.

    Onconova Therapeutics Inc. (ONTX) stock soar by 1.75% to $0.32. On November 23, 2020, the company reported the filing of an investigational new drug application for Multi-kinase CDK4/6 Inhibitor ON 123300. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy.

  • What changed for these 30 stocks in Pre Market Session

    What changed for these 30 stocks in Pre Market Session

    Usio Inc. (USIO) stock soared 41.54% to $2.59 in the pre-market trading after declaring that it has entered into a non-binding Letter of Intent (LOI) to acquire the assets of Information Management Solutions, LLC (IMS).
    NeuroMetrix Inc. (NURO), a Medical Instruments & Supplies company, dropped about -8.03% at $2.75 in pre-market trading Wednesday.
    Cinedigm Corp. (CIDM) stock moved up 43.36 percent to $1.23 in the pre-market trading following a strategic alliance with Spherex to drive Cinedigm’s global growth.
    Recon Technology Ltd. (RCON) stock moved up 112.5 percent to $3.06 in the pre-market trading.
    Curis Inc. (NASDAQ: CRIS) shares are trading up 2.29% at $6.7 at the time of writing after revealing proposed public offering of common Stock. Company’s 52-week ranged between $0.62 to $3.59. Analysts have a consensus price target of $5.
    Gran Tierra Energy Inc. (GTE) lost over -7.04% at $0.355 in pre-market trading Wednesday December 09, 2020. The firm recently declared a financial update and the Company’s 2021 capital budget and production guidance.
    Aurora Cannabis Inc. (ACB) is down more than -0.94% at $10.5 in pre-market hours Wednesday December 09, 2020. The stock had jumped over 1.24% to $10.60 in the last trading session.
    Carnival Corporation & Plc (CCL) is up more than 2.76% at $24.22 in pre-market hours Wednesday December 09, 2020 following declaration of Cunard, a part of Carnival Corporation & plc (CCL), that it has extended its pause in operations due to the ongoing travel constraints in place across the world. The stock had jumped over 1.59% to $23.57 in the last trading session.
    Before the trading started on December 09, 2020, Occidental Petroleum Corporation (OXY) is up 2.56% to reach $19.62 after reporting upsize of previously announced cash tender offers and consent solicitations for certain of its senior notes. It has been trading in a 52-week range of $8.52 to $47.58.
    Virgin Galactic Holdings Inc. (SPCE) stock soared 2.55% to $34.24 in the pre-market trading. The most recent rating by Goldman, on October 23, 2020, is a Neutral.
    Eastman Kodak Company (NYSE: KODK) shares are trading down -4.04% at $10.7 at the time of writing after getting clean chit from U.S government regarding a government loan. Company’s 52-week ranged between $1.50 to $60.00.
    Moderna Inc. (MRNA) grew over 3.38% at $175.6 in pre-market trading today after declaring that the Swiss Federal Government has increased its confirmed order commitment from 4.5 million to 7.5 million doses of Moderna’s vaccine candidate against COVID-19, mRNA-1273.
    Riot Blockchain Inc. (RIOT), a Software – Application company, dropped about -5.78% at $9.3 in pre-market trading Wednesday.
    Norwegian Cruise Line Holdings Ltd. (NCLH), a Travel Services company, rose about 1.95% at $28.7 in pre-market trading Wednesday after announcing partnership with AtmosAir Solutions.
    XPeng Inc. (XPEV) stock moved down -3.72 percent to $46.88 in the pre-market trading following the pricing of follow-on public offering of American depositary shares.
    Cinemark Holdings Inc. (CNK) stock soared 2.26% to $15.36 in the pre-market trading. The most recent rating by Loop Capital, on November 19, 2020, is a Hold.
    Before the trading started on December 09, 2020, Tonix Pharmaceuticals Holding Corp. (TNXP) is up 0.15% to reach $0.65 after declaring results of positive phase 3 RELIEF study for TNX-102 SL 5.6 mg in Fibromyalgia. It has been trading in a 52-week range of $0.39 to $2.46.
    CBAK Energy Technology Inc. (NASDAQ: CBAT) shares are trading up 3.3% at $5.95 at the time of writing following the publication of securities purchase agreement with certain institutional investors for a registered direct placement of approximately $49.2 million of common stock at a price of $5.18 per share. Company’s 52-week ranged between $0.36 to $11.40.
    Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -4.84% at $0.3798 at the time of writing. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target of $2.
    United Airlines Holdings Inc. (UAL) grew over 1.88% at $49.96 in pre-market trading today after launching virtual, on demand customer service at the airport.
    GameStop Corp. (GME) is down more than -17.59% at $13.96 in pre-market hours Wednesday December 09, 2020 after releasing results for the third quarter ended October 31, 2020. The stock had jumped over 3.61% to $16.94 in the last trading session.
    Before the trading started on December 09, 2020, ADMA Biologics Inc. (ADMA) is up 4.31% to reach $2.18. It has been trading in a 52-week range of $1.45 to $4.65.
    Before the trading started on December 09, 2020, HEXO Corp. (HEXO) is down -2.91% to reach $1.0. The firm recently reported downward revision to its proposed share consolidation ratio. It has been trading in a 52-week range of $0.35 to $2.30.
    United Microelectronics Corporation (UMC) is up more than 1.37% at $8.88 in pre-market hours Wednesday December 09, 2020 afterreporting unaudited net sales for the month of November 2020. The stock had dropped over -3.10% to $8.76 in the last trading session.
    Apache Corporation (NASDAQ: APA) shares are trading up 1.08% at $14.92 at the time of writing following the board of directors of Apache Corporation (APA) has declared a regular cash dividend on the company’s common shares. Company’s 52-week ranged between $3.80 to $33.77. Analysts have a consensus price target of $16.
    Phunware Inc. (PHUN) stock moved down -3.28 percent to $0.81 in the pre-market trading after revealing its receipt of the Privacy Shield certification.
    Sorrento Therapeutics Inc. (SRNE) stock soared 9.62% to $8.66 in the pre-market trading after declaring that it has received CLIA Licensure from the State of California that permits testing of clinical samples. The most recent rating by H.C. Wainwright, on July 31, 2020, is a Buy.
    Sesen Bio Inc. (SESN) gained over 5.42% at $1.75 in pre-market trading Wednesday December 09, 2020 following the announcement of commercial manufacturing and global supply partnership with Qilu Pharmaceutical.
    Before the trading started on December 09, 2020, Futu Holdings Limited (FUTU) is up 2.27% to reach $44.61 after reporting that a leading global investment firm has agreed to purchase approximately 50,000,000 Class A ordinary shares of the Company in the form of prepaid warrants for an aggregate purchase price of approximately US$260,000,000. It has been trading in a 52-week range of $8.16 to $51.10.
    Westwater Resources Inc. (WWR) stock soared 3.87% to $5.63 in the pre-market trading. The company recently provided an update on progress at its pilot plant operations at Dorfner Anzaplan’s facilities near Amberg, Germany, as well as at facilities in Frankfort, Germany, Chicago, Illinois, and Buffalo, New York.

  • 18 Biotech Stocks That Are Great Options To Invest In

    18 Biotech Stocks That Are Great Options To Invest In

    The biotech industry is considered to be an attractive industry for the investor. This industry is continuously adopting new technological advancements. As time passes by every aspect of daily existence experience changes because of new technological breakthroughs and advancement in knowledge. Technology plays an important role in changing the lifestyle of humans. This technology also plays a very important role in the biotech industry.

    This technology has historically grown quickly. The biotech industry is striving to develop a treatment for complex diseases. It is anticipated that in 2021, one of the continuing trends in biotech is the continued improvement and development of drug research. The new technology help researchers to improve and assess diagnosis and treatment using medications.

    Check out the top 18 biotech companies you should add to your portfolio:

    BioLineRx Ltd. (NASDAQ: BLRX)

    BioLineRx Ltd. (NASDAQ: BLRX) shares were trading up 33.78% at $1.98 at the time of writing on Friday. BioLineRx Ltd. (NASDAQ: BLRX) share price went from a low point around $1.06 to briefly over $3.04 in the past 52 weeks, though shares have since pulled back to $1.98. BLRX market cap has remained high, hitting $39.57M at the time of writing. BioLineRx Ltd. (BLRX) has earlier announced the promising results from the ongoing GENESIS Phase III trial motixafortide for stem cell mobilization (SCM) in multiple myeloma patients.

    Miragen Therapeutics Inc. (NASDAQ: MGEN)

    Miragen Therapeutics Inc. (NASDAQ: MGEN) last closed at $1.31, in a 52-week range of $0.31 to $2.27. Miragen Therapeutics Inc. (MGEN) has earlier acquired  Viridian Therapeutics, Inc. It has traded up 321.22% and traded down -42.29% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 4.80 and a quick ratio of 4.80. This company has a market capitalization of $79.29 million at the time of writing.

    Equillium Inc. (NASDAQ: EQ)

    Equillium Inc. (NASDAQ: EQ) stock soar by 5.83% to $6.35. The most recent rating by H.C. Wainwright, on July 14, 2020, is at a Buy. Previously, Equillium Inc. (EQ) has revealed that it has received a ‘Study May Proceed letter’ from the U.S. Food and Drug Administration (FDA) to commence a Phase 3 clinical trial, titled  EQUINOX, evaluating itolizumab in hospitalized COVID-19 patients suffering from acute respiratory distress syndrome (ARDS).

    Titan Pharmaceuticals Inc. (NASDAQ: TTNP)

    Titan Pharmaceuticals Inc. (NASDAQ: TTNP) shares headed falling, lower as much as -3.24%. The most recent rating by Maxim Group, on June 26, 2019, is at a Buy. Titan Pharmaceuticals Inc. (TTNP) revealed the pricing of an underwritten public offering of 80,000,000 units at a price of $0.10 per unit. Each unit issued in the offering comprised of one share of common stock and one warrant to purchase one share of common stock.

    Trevena Inc. (NASDAQ: TRVN)

    Trevena Inc. (NASDAQ: TRVN) rose 2.34% after gaining more than $0.06 on Friday. Trevena Inc. (TRVN) has disclosed that oliceridine has been classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA). Looking at its liquidity, it has a current ratio of 16.20 and a quick ratio of 16.20. This company has a market capitalization of $381.29 million at the time of writing.

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) last closed at $6.94, in a 52-week range of $1.45 to $19.39. Sorrento Therapeutics Inc. (SRNE) has earlier announced preclinical data about intravenous COVI-AMG™ (STI-2020; Affinity Matured COVI-GUARD) neutralizing antibody (nAb) in a preprint publication.

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) shares headed falling, lower as much as -1.69%. The most recent rating by Alliance Global Partners, on June 26, 2020, is at a Buy. iBio Inc. (IBIO) has earlier appointed Dr. Alexandra Kropotova to its Board of Directors, effective as of October 14, 2020. Dr. Kropotova has also been chosen as a member of iBio’s new Science & Technology Committee, which shall be chaired by Dr. Philip Russell.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) fall -6.10% after losing more than -$0.64 on Friday. Inovio Pharmaceuticals Inc. (INO) announced that it is scheduled to release its third-quarter financial results of 2020 on November 9, 2020.  This company has a market capitalization of $1.76 billion at the time of writing.

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (NASDAQ: VXRT) last closed at $4.92, in a 52-week range of $0.27 to $17.49. A class action has started on behalf of certain shareholders in Vaxart, Inc. It has traded up 1749.62% and traded down -71.87% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 4.00 and a quick ratio of 4.00. This company has a market capitalization of $580.22 million at the time of writing.

    Axovant Gene Therapies Ltd. (NASDAQ: AXGT)

    Axovant Gene Therapies Ltd. (NASDAQ: AXGT) stock drop by -41.64% to $2.13. The most recent rating by Cantor Fitzgerald, on April 17, 2020, is at an Overweight. Axovant Gene Therapies Ltd. (AXGT) has earlier announced program updates on Friday, October 30, 2020, at 11:30 AM Eastern time, for the Company’s AXO-Lenti-PD gene therapy for Parkinson’s disease.

    Akebia Therapeutics Inc. (NASDAQ: AKBA)

    Akebia Therapeutics Inc. (NASDAQ: AKBA) shares headed falling, lower as much as -2.20%. The most recent rating by Needham, on November 14, 2019, is at a Buy. Akebia Therapeutics Inc. (AKBA) earlier revealed that it is scheduled to announce its financial results for the third quarter ended September 30, 2020, on November 5, 2020, before the opening of the market.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) fall -5.35% after losing more than -$3.81 on Friday. Moderna Inc. (MRNA) earlier revealed that it has been recognized as one of the global biopharmaceutical industry’s top employers in Science and ScienceCareers’ 2020 Top Employers Survey for the sixth consecutive year.

    Heat Biologics Inc. (NASDAQ: HTBX)

    Heat Biologics Inc. (NASDAQ: HTBX) stock soar by 3.45% to $1.20. The most recent rating by B. Riley Securities, on October 14, 2020, is at a Buy. Heat Biologics Inc. (HTBX) share price went from a low point around $0.19 to briefly over $4.30 in the past 52 weeks, though shares have since pulled back to $1.20. HTBX market cap has remained high, hitting $172.30 Million at the time of writing.

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) last closed at $0.26, in a 52-week range of $0.10 to $1.56. Onconova Therapeutics Inc. (ONTX) revealed that Dr. Steven M. Fruchtman, President and Chief Executive Officer, will present a company update during the 2020 BIO Investor Forum Digital event taking place October 13-15.

    Clovis Oncology Inc. (NASDAQ: CLVS)

    Clovis Oncology Inc. (NASDAQ: CLVS) stock drop by -4.27% to $4.93. The most recent rating by H.C. Wainwright, on May 18, 2020, is at a Buy. Clovis Oncology Inc. (CLVS) is scheduled to release its third-quarter 2020 financial results on Thursday, November 5, 2020, before the open of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30 a.m.

    BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)

    BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares headed rising, higher as much as 2.41%. The most recent rating by JP Morgan, on September 29, 2020, is at an Overweight. BioCryst Pharmaceuticals Inc. (BCRX) revealed that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted oral, once-daily berotralstat a positive scientific opinion through the Early Access to Medicines Scheme (EAMS).

    Soligenix Inc. (NASDAQ: SNGX)

    Soligenix Inc. (NASDAQ: SNGX) rose 0.59% after gaining more than $0.01 on Friday. Soligenix Inc. (SNGX) has disclosed that continued optional treatment with SGX301 across all lesions during the compassionate use, safety portion of the trial (Cycle 3), for a total of 6 months in the study, continued to significantly improve responses and remained safe and well-tolerated in its FLASH study.

    Scholar Rock Holding Corporation (SRRK)

    Scholar Rock Holding Corporation (SRRK) last closed at $38.90, in a 52-week range of $6.95 to $46.50. Analysts have a consensus price target of $30.00. Scholar Rock Holding Corporation (SRRK) announced the pricing of an underwritten public offering of 2,948,718 shares of its common stock at a public offering price of $39.00 per share.

  • Here’s Why You Should Hold These 15 Biotech Stocks

    Here’s Why You Should Hold These 15 Biotech Stocks

    The biotechnology industry is considered to be an attractive industry for investors as the investors are always looking for safe and secure investments. This industry is a good option for investors as it is a strong and profitable industry. Companies in the biotechnology industry are continuously striving and exploring treatment for rare diseases. This industry has a significant contribution to the well-being of society. The biotechnology industry is constantly experiencing tech improvements and new scientific discoveries.

    Technology has always been at the heart of the biotechnology industry. New technological advancements are helpful for the biotechnology industry. This industry is anticipated to show a higher growth rate over the period of the next seven years. Globally, it is predicted that this industry will generate massive revenue in the coming years and it will also provide investment opportunities to investors who want to invest in the research and development of this industry.

    The following are the leading companies in the biotechnology industry. Let check how these companies are providing the best services to their clients:

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares were trading down -10.49% at $9.30 at the time of writing on Friday. Sorrento Therapeutics Inc. (NASDAQ: SRNE) share price went from a low point around $1.45 to briefly over $19.39 in the past 52 weeks, though shares have since pulled back to $9.30. SRNE market cap has remained high, hitting $2.72B at the time of writing, giving it a price-to-sales ratio of more than 70.

    Sorrento Therapeutics Inc. (SRNE) has announced earlier that it has secured the receipt of clearance from a Brazilian regulatory agency to continue with a Phase 2 clinical trial of Abivertinib in mild, moderate, and severe COVID-19 patients. If we look at the recent analyst rating SRNE, H.C. Wainwright reiterated coverage on SRNE shares with a Buy rating.

    EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT)

    EyePoint Pharmaceuticals Inc. (EYPT) last closed at $0.48, in a 52-week range of $0.46 to $2.69. EyePoint Pharmaceuticals Inc. (EYPT) revealed changes to its existing debt facility with CRG Servicing LLC (CRG). Under the terms of the amendment, CRG has waived the covenant associated with the Company’s net product revenue of DEXYCU and YUTIQ for the twelve-month period ending on December 31, 2020.

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (VXRT) stock drop by -3.49% to $6.08. The most recent rating by H.C. Wainwright, on August 12, 2020, is at a Buy. The Schall Law Firm disclosed that the class-action lawsuit has been lodged against Vaxart, Inc. (VXRT)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

    Novan Inc. (NASDAQ: NOVN)

    Novan Inc. (NASDAQ: NOVN) shares headed falling, lower as much as -4.59%. The most recent rating by Piper Jaffray, on January 06, 2020, is at a Neutral. Novan Inc. (NOVN) revealed earlier that the positive in vitro results exhibited the potential efficacy of its NITRICIL™ platform technology as an antiviral against SARS-CoV-2, the virus that causes COVID-19.

    Akebia Therapeutics Inc. (NASDAQ: AKBA)

    Akebia Therapeutics Inc. (NASDAQ: AKBA) rose 3.42% after gaining more than $0.13 on Friday. Akebia Therapeutics Inc. (AKBA) revealed that it is scheduled to present data from its global Phase 3 programs of vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis ) and not on dialysis at the American Society of Nephrology Kidney Week 2020 Reimagined (ASN Kidney Week) on October 22 – 25, 2020.

    Royalty Pharma plc (NASDAQ: RPRX)

    Royalty Pharma plc (RPRX) last closed at $41.81, in a 52-week range of $38.54 to $56.50. Analysts have a consensus price target of $52.67. Royalty Pharma plc (RPRX) disclosed today that it is scheduled to announce its third-quarter 2020 financial results on Wednesday, November 11, 2020, before the U.S. financial markets open.

    Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

    Vertex Pharmaceuticals Incorporated (VRTX) stock soar by 1.30% to $218.08. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Vertex Pharmaceuticals Incorporated (VRTX) shared an update on its clinical programs targeting the small molecule correction of alpha-1 antitrypsin deficiency (AATD).

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) Shares headed falling, lower as much as -1.44%. The most recent rating by Alliance Global Partners, on June 26, 2020, is at a Buy. iBio Inc. (IBIO) earlier revealed it has appointed Dr. Alexandra Kropotova to its Board of Directors, effective as of October 14, 2020. Dr. Kropotova has also been chosen as a member of iBio’s new Science & Technology Committee, which shall be chaired by Dr. Philip Russell.

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) last closed at $0.29, in a 52-week range of $0.10 to $1.56. Onconova Therapeutics Inc. (ONTX) earlier disclosed that Dr. Steven M. Fruchtman, President and Chief Executive Officer, will present a company update during the 2020 BIO Investor Forum Digital event taking place October 13-15. Dr. Fruchtman and Avi Oler, Senior VP, Corporate Development, will be available for 1×1 meetings scheduled through the Bio Partnering system.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) Shares headed falling, lower as much as -2.17%. The most recent rating by SVB Leerink, on September 08, 2020, is at an Underperform. Moderna Inc. (MRNA) has earlier disclosed the initiation of a rolling submission to Health Canada for mRNA-1273. This initiation follows positive results from a preclinical viral challenge study of mRNA-1273 and the positive interim analysis of the Phase 1 study of mRNA-1273 in healthy adults and older adults.

    Selecta Biosciences Inc. (NASDAQ: SELB)

    Selecta Biosciences Inc. (NASDAQ: SELB) rose 18.01% after gaining more than $0.38 on Friday. Selecta Biosciences Inc. (SELB) has earlier announced an agreement with IGAN Biosciences, Inc. The agreement is the Research License and Option agreement signed to study Selecta’s ImmTOR™ immune tolerance platform in combination with IGAN’s immunoglobulin A (IgA) protease for the treatment of IgA Nephropathy (IgAN).

    Immunomedics Inc. (NASDAQ: IMMU)

    Immunomedics Inc. (NASDAQ: IMMU) stock soar by 0.08% to $87.56. The most recent rating by Barclays, on May 05, 2020, is at an Overweight. Immunomedics Inc. (IMMU) disclosed that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Trodelvy orphan status for the treatment of adult and pediatric patients with glioblastoma.

    Clovis Oncology Inc. (NASDAQ: CLVS)

    Clovis Oncology Inc. (NASDAQ: CLVS) fall -0.75% after losing more than -$0.05 on Friday. Clovis Oncology Inc. (CLVS) share price went from a low point around $2.93 to briefly over $17.37 in the past 52 weeks. It has moved up 102.56% from its 52-weeks low and moved down -65.83% from its 52-weeks high. CLVS market cap has remained high, hitting $532.72 million at the time of writing.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock drop by -2.95% to $11.85. The most recent rating by Maxim Group, on September 28, 2020, is at a Buy. Inovio Pharmaceuticals Inc. (INO) share price went from a low point around $2.09 to briefly over $33.79 in the past 52 weeks. It has moved up 456.84% from its 52-weeks low and moved down -65.56% from its 52-weeks high. INO market cap has remained high, hitting $2.05 Billion at the time of writing.

    MannKind Corporation (NASDAQ: MNKD)

    MannKind Corporation (NASDAQ: MNKD) last closed at $2.00, in a 52-week range of $0.80 to $2.48. MannKind Corporation (MNKD) has moved up 157.08% from its 52-weeks low and moved down -17.07% from its 52-weeks high. MNKD market cap has remained high, hitting $441.20 Million at the time of writing.

  • Sorrento Therapeutics Reports Data On STI-1499 And STI-2020 Neutralizing Antibodies Against SARS-CoV-2

    Sorrento Therapeutics Reports Data On STI-1499 And STI-2020 Neutralizing Antibodies Against SARS-CoV-2

    Sorrento Therapeutics, Inc. (NASDAQ: SRNE) announced today the result of COVI-GUARD™ (STI-1499) and COVI-AMG™ (STI-2020) neutralizing antibodies (nAbs) against SARS-CoV-2. Both the STI-1499 and STI-2020 antibodies have shown the neutralizing activities against SARS-CoV-2 virus infection in preclinical models.

    STI-1499 neutralizing antibody has earlier received the green signal from the FDA in the Phase 1 clinical trial in hospitalized COVID-19 patients. While the STI-2020 is a matured version of the COVI-GUARD neutralizing antibody and has shown a greater than 50-fold increase in potency in Invitro experiments. Both the neutralizing antibodies have demonstrated 100% In vitro neutralization of SARS-CoV-2.

    STI-1499 and STI-2020 nAb has shown the promising result in the pre-clinical studies. Hamsters that are infected with coronavirus when received the single dose of STI-2020 have gained within 48 hours after the injection of neutralizing antibodies. It has been disclosed that the 500 µg single dose of STI-2020 injected in hamsters in the preclinical studies would be equivalent to a human dose of less than 100 mg of antibody.

    As compared to other medical treatment for SAR-CoV-2, this antibody has shown very promising results at a low dose. Therefore, it is considered that the COVI-AMG could potentially be injected as a simple and rapid injection to treat COVID-19 patients. The company has earlier received FDA authorization for STI-1499 to treat hospitalization COVID-19 patient and the company is planning to submit IND for STI-2020 soon.

    Sorrento Therapeutics has also reported the positive Phase 1b trial data of resiniferatoxin (RTX). The data revealed that the RTX has not shown any negative safety signal as of September. The Phase 1b trial has been conducted to study the effectiveness of resiniferatoxin (RTX) for the treatment of moderate to severe pain due to osteoarthritis (OA) of the knee.

    The Phase 1b trial of RTX has shown the encouraging results and the company has now decided to start the Phase 2 clinical trial of an investigational drug product in 2020. It is expected that the Phase 3 clinical trial will start in 2021 after completing additional enabling preclinical studies.

    Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares were trading up 4.73% at $10.63 at the time of writing on Tuesday. Sorrento Therapeutics, Inc. share price went from a low point around $1.39 to briefly over $19.39 in the past 52 weeks. It has moved up 664.76% from its 52-weeks low and moved down -45.18% from its 52-weeks high. SRNE market cap has remained high, hitting $2.47 billion at the time of writing.